Peritoneal Cavity Cancer clinical trials at UCSF
1 research study open to eligible people
Peritoneal cavity cancer is cancer that starts in the lining of the abdomen. UCSF is studying new drugs for solid tumors that affect the peritoneal cavity. One study evaluates an investigational targeted drug in participants with certain solid tumors.
Showing trials for
XMT-1660 in Participants With Solid Tumors
open to eligible people ages 18 years and up
A Study of XMT-1660 in Solid Tumors
San Francisco, California and other locations
Our lead scientists for Peritoneal Cavity Cancer research studies include Laura Huppert.
Last updated: